FDA.reportPublic FDA data

everolimus 5 MG Tablet for Oral Suspension

RxCUI
1308432
RxNorm name
everolimus 5 MG Tablet for Oral Suspension
Display name
everolimus 5 MG Tablet for Oral Suspension
Full name
everolimus 5 MG Tablet for Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2150f73a-179b-4afc-b8ce-67c85cc72f04everolimus 5 MG Tablet for Oral SuspensionPSN66These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 200920260212
2150f73a-179b-4afc-b8ce-67c85cc72f04everolimus 5 MG Tablet for Oral SuspensionSCD66These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 200920260212
01f7b5fb-be0d-4adf-acd2-6899018de966everolimus 5 MG Tablet for Oral SuspensionSCD20These highlights do not include all the information needed to use EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION. EVEROLIMUS tablets, for oral use EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 200920250905
01f7b5fb-be0d-4adf-acd2-6899018de966everolimus 5 MG Tablet for Oral SuspensionPSN20These highlights do not include all the information needed to use EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION. EVEROLIMUS tablets, for oral use EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 200920250905
5b809dfe-c076-07c5-207e-178c3f0d32d3everolimus 5 MG Tablet for Oral SuspensionPSN5These highlights do not include all the information needed to use EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS FOR ORAL SUSPENSION . EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 200920260114
5b809dfe-c076-07c5-207e-178c3f0d32d3everolimus 5 MG Tablet for Oral SuspensionSCD5These highlights do not include all the information needed to use EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS FOR ORAL SUSPENSION . EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 200920260114
6f1ae129-c21e-4c25-84c1-a6757d9a7eb2everolimus 5 MG Tablet for Oral SuspensionPSN4These highlights do not include all the information needed to use EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS FOR ORAL SUSPENSION . EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 200920260409
6f1ae129-c21e-4c25-84c1-a6757d9a7eb2everolimus 5 MG Tablet for Oral SuspensionSCD4These highlights do not include all the information needed to use EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS FOR ORAL SUSPENSION . EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 200920260409